Vera Therapeutics VERA 深 沪
等待开盘 09-10 09:30:00 美东时间
25.08
+0.330
+1.33%
华盛通- 最 高25.29
- 今 开24.435
- 成交量 231.14万股
- 最 低 24.435
- 昨 收 24.75
- 总市值 15.99亿
- 52周最高 51.61
- 市盈率 静 --
- 换手率 3.62%
- 52周最低 18.53
- 委 比 -5.15%
- 总股本 6377.42万
- 历史最高 51.61
- 量 比 1.06
- 振 幅 3.45%
- 历史最低 5.20
- 每 手 1
- 风险率 9.81%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多RedHill Biopharma Announces First Half 2025 Financial Results and Operational Highlights
Extensive strategic, financial and operational overhaul has reshaped and refocused our business; Strong progress on multiple fronts Commercial and R&D Highlights: Recruitment initiated in th...
09-05 19:00
FDA Eases Monitoring Burden For Kidney Disease Patients On Travere Therapeutics' Filspari
FDA eases REMS labeling for Travere's Filspari, reducing liver monitoring and removing embryo-fetal toxicity rules, with FSGS approval review ongoing.
08-29 00:40
Vera Therapeutics to Participate at Upcoming Investor Conferences
Vera Therapeutics announced that its management team will participate in upcoming investor conferences, including the Cantor Global Healthcare Conference on September 4, 2025, and the Morgan Stanley 23rd Annual Global Healthcare Conference on September 8, 2025. Both events will feature Fireside Chats and one-on-one meetings in New York. Vera focuses on developing treatments for immunological diseases, with its lead candidate, atacicept, targeting...
08-26 20:05
Vera Bradley Brings a Fan’s Teenage Dream to Life in an Original Short Film
Vera Bradley releases its first original short film, *Most Perfect Couple*, inspired by a 2002 fan fiction story written by Kristen Mulrooney. The film revisits the millennial teen heartthrob era, featuring Mulrooney as her teenage self alongside Devon Sawa. The brand aims to celebrate multi-generational self-expression and joy through the nostalgic tale. Fans can watch the film on Vera Bradley’s social channels and shop the featured bags and acc...
08-19 13:00
减肥药赛道卷向脂肪肝！全球首个治疗脂肪肝的减肥药获批，国内进展如何？
GLP-1（胰高血糖素样肽-1）减肥药的适应证天花板被进一步打开，也将这一热门赛道的竞争卷到了脂肪肝领域。 当地时间8月15日，诺和诺德对外宣布，减重版司美格鲁...
08-19 07:03
美股大行评级 | DoorDash获上调目标价从230美元升至300美元； 摩根大通上调Shopify目标价从115美元升至179美元
今日重点评级关注：HC Wainwright & Co.：维持FibroGen"买入"评级，目标价从10美元升至43美元；摩根大通：维持Cogent Biosciences"超配"评级，目标价从29美元升至30美元
08-08 09:34
Vera Therapeutics Q2 2025 EPS $(1.20) Misses $(0.83) Estimate, Vera Reported $556.8M In Cash, Cash Equivalents, And Marketable Securities
Vera expects cash position to be sufficient to fund operations through potential approval and us commercial launch of Atacicept anticipated in 2026 and beyond
08-05 19:13
Vera Therapeutics Provides Business Update and Reports Second Quarter 2025 Financial Results
Vera Therapeutics announced positive clinical results from the ORIGIN 3 trial of atacicept for IgA Nephropathy (IgAN), demonstrating a significant reduction in proteinuria and a favorable safety profile. The company plans to submit a Biologics License Application (BLA) for accelerated approval to the U.S. FDA in Q4 2025, with a potential commercial launch in 2026. Vera also initiated the PIONEER trial to evaluate atacicept in broader IgAN populat...
08-05 11:00
